Giant cell arteritis

Código QR

Giant cell arteritis

Giant cell arteritis (GCA) is the most common vasculitis of older age. It usually affects the branches of carotid arteries, especially temporal and ophthalmic artery. In addition to genetic predisposition, environmental factors also contribute to the development of the disease. Interleukin 6 (IL-6),...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Dijana Perković, Simeon Grazio, Tatjana Kehler, Jadranka Morović Verglas, Srđan Novak, Višnja Prus, Branimir Anić
Formato:	article
Lenguaje:	EN HR
Publicado:	Hrvatski liječnički zbor 2021
Materias:	giant cell arteritis – diagnosis drug therapy physiopathology; temporal arteries – pathology; interleukin-6 – blood physiology; c-reactive protein – analysis; polymyalgia rheumatica – complications; optic neuropathy ischemic – complications; glucocorticoids – therapeutic use; receptors interleukin-6 – antagonists and inhibitors; antibodies monoclonal Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/05a8d20fc6eb4c8789175f7489c33413
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Caso radiológico de desafío diagnóstico
por: Weisz C.,José Tomás, et al.
Publicado: (2019)

A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon E, et al.
Publicado: (2019)

Biologic Therapies for Giant Cell Arteritis
por: Harrington R, et al.
Publicado: (2021)

Whole-Body [<sup>18</sup>F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease
por: Matthias Fröhlich, et al.
Publicado: (2021)

Isquemia de extremidades inferiores secundaria a arteritis de la arteria temporal
por: Zárate B.,Cristian, et al.
Publicado: (2020)

Temporal arteritis with erythrocyte sedimentation rate <50 mm/h: a clinical reminder
por: Cheema MR, et al.
Publicado: (2016)

Polymyalgia rheumatica following infective triggersor vaccinations: a different subset of disease?
por: Paolo Falsetti, et al.
Publicado: (2020)

Bases fisiopatológicas para una clasificación de la neuropatía diabética
por: Olmos,Pablo R, et al.
Publicado: (2012)

Presentation and Real-World Management of Giant Cell Arteritis (Artemis Study)
por: Alfred Mahr, et al.
Publicado: (2021)

“CVCACS” MODEL FOR PREDICTION OF CARDIOVASCULAR COMPLICATIONS IN HOSPITALIZED PATIENTS WITH ACUTE CORONARY SYNDROME
por: E. T. Manyukova, et al.
Publicado: (2015)

Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements
por: Dammacco R, et al.
Publicado: (2020)

Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature
por: Ciro Manzo, et al.
Publicado: (2020)

Not just pain and morning stiffness duration in the daily experience of patients with polymyalgia rheumatica. Does the rheumatologist listen to all patient-reported outcomes?
por: Ciro Manzo, et al.
Publicado: (2021)

Clinical, radiological, and biochemical characteristics in patients with diseases mimicking polymyalgia rheumatica
por: Hidekatsu Yanai, et al.
Publicado: (2009)

Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?
por: Ciro Manzo, et al.
Publicado: (2020)

Polymyalgia rheumatica: observations of disease evolution without corticosteroid treatment
por: Brawer AE
Publicado: (2016)

Functionally Heterogenous Macrophage Subsets in the Pathogenesis of Giant Cell Arteritis: Novel Targets for Disease Monitoring and Treatment
por: Idil Esen, et al.
Publicado: (2021)

Giant cell arteritis presenting as a stroke in the internal carotid artery territory: a case-based review
por: Edoardo Conticini, et al.
Publicado: (2021)

Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
por: Ciro Manzo, et al.
Publicado: (2021)

Subjective sleep disturbances at the time of diagnosis in patients with polymyalgia rheumatica and in patients with seronegative elderly-onset rheumatoid arthritis. A pilot study
por: Ciro Manzo, et al.
Publicado: (2020)

ASSOCIATION OF IL-1β, IL-4 AND IL-6 GENES POLYMORPHISMS WITH GENETIC PREDISPOSITION FOR AUTOIMMUNE THYROIDITIS
por: E. M. Biktagirova, et al.
Publicado: (2014)

Arteritis de células gigantes: actualización y proposición de un algoritmo de estudio
por: Wolff C,Verónica, et al.
Publicado: (2020)

Polymyalgia rheumatica and cancer risk: the importance of the diagnostic set
por: Manzo C, et al.
Publicado: (2016)

Arteritis de células gigantes en el sistema vertebrobasilar, isquemias cerebelo-occipitales y parálisis III par. Caso clínico
por: Adolfo,Del Canto A., et al.
Publicado: (2018)

Acute vision loss and choroidal filling delay in the absence of giant-cell arteritis
por: Bei L, et al.
Publicado: (2016)

Temporal arteritis, Sjögren’s syndrome and mixed pain components as manifestations in a diabetic older adult: systematic review based on a case report
por: Fernando M. Runzer-Colmenares, et al.
Publicado: (2020)

Arteritis de células gigantes: compromiso extenso de la aorta y grandes ramas demostrado por tomografía por emisión de positrones. Caso clínico
por: Grünholz,Daniela, et al.
Publicado: (2016)

Estudio de la cinética de citoquinas en sepsis grave y su relación con mortalidad y score de disfunción orgánica
por: Dougnac L,Alberto, et al.
Publicado: (2001)

Novelties in etiopathogenesis, diagnosis and treatment of patients with lumbar intevrertebral disc degeneration
por: Simeon Grazio, et al.
Publicado: (2021)

Elevated serum Il-6 and adiponectin levels are associated with frailty and physical function in Chinese older adults
por: Ma L, et al.
Publicado: (2018)

Niveles plasmáticos de citoquinas IL-1ß, IL2 e IL-4 en niños diabéticos tipo 1 de diagnóstico reciente y su asociación con anticuerpos ß pancreáticos
por: Pérez B,Francisco, et al.
Publicado: (2004)

El comportamiento del factor de necrosis tumoral alfa e interleucina 6 en lesiones de vías biliares postcolecistectomía
por: MIRANDA-DÍAZ,ALEJANDRA G, et al.
Publicado: (2010)

Polimorfismo -174 G/C del gen promotor de interleuquina 6 en mujeres con diabetes mellitus tipo 1
por: PÉREZ-BRAVO,FRANCISCO, et al.
Publicado: (2011)

Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up
por: Laria A, et al.
Publicado: (2017)

PET-CT FDG en el diagnóstico y seguimiento de vasculitis de grandes vasos
por: Vicentela I.,Andrés, et al.
Publicado: (2021)

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
por: Vadim V. Genkel, et al.
Publicado: (2018)

The Effect of Transcutaneous Vagus Nerve Stimulation in Patients with Polymyalgia Rheumatica
por: Jacob Venborg, et al.
Publicado: (2021)

Positive correlation between tumor necrosis factor (TNF)-α and cardiorespiratory fitness after six-months of regular aerobic exercise in Peruvian Amerindian women
por: Lindgärde,Folke, et al.
Publicado: (2011)

Neural network and logistic regression diagnostic prediction models for giant cell arteritis: development and validation
por: Ing EB, et al.
Publicado: (2019)

Comparison of Interleukin-6 Plasma Concentration in Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Pediatric Sepsis
por: Franco Diaz, et al.
Publicado: (2021)